Reference
Hegde U, et al. Myasthenic syndrome with pembrolizumab use. Neurology 88 (Suppl. 16): Apr 2017 [abstract] - USA
Rights and permissions
About this article
Cite this article
Pembrolizumab. Reactions Weekly 1658, 375 (2017). https://doi.org/10.1007/s40278-017-32571-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-32571-2